secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001193125-25-274383
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon corrects prospectus error on EY internal control audit exemption
------------------------------------------------------------------------

- Prospectus supplement inadvertently stated EY audited internal controls as of Dec 31, 2024.
- As a smaller reporting company/non-accelerated filer, Lexicon is exempt from such audit; EY did not perform it.
- Correction relates to existing $75M at-the-market equity facility with Jefferies LLC.
- No impact on financial statements or current business operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000119312525274383/0001193125-25-274383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000119312525274383/d30705d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-274383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer